Cargando…

Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression

BACKGROUND: Electroconvulsive therapy (ECT) has long been used for treating individuals with treatment-resistant depression (TRD). Esketamine has recently emerged as a new treatment for TRD due to its rapid antidepressant effects. To further inform the decision regarding choice of treatment, this pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Degerlund Maldi, Kinza, Asellus, Peter, Myléus, Anna, Norström, Fredrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650406/ https://www.ncbi.nlm.nih.gov/pubmed/34876085 http://dx.doi.org/10.1186/s12888-021-03601-8

Ejemplares similares

Electroconvulsive therapy vs Esketamine among patients with Major Depressive Episode
por: Basto, M. D. R. D. R. F. D. A., et al.
Publicado: (2023)

Widespread and widely widening? Examining absolute socioeconomic health inequalities in northern Sweden across twelve health indicators
por: Degerlund Maldi, Kinza, et al.
Publicado: (2019)

Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
por: Rognoni, Carla, et al.
Publicado: (2023)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Esketamine hydrochloride for treatment-resistant depression
Publicado: (2021)

The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

Depression, memory and electroconvulsive therapy
por: Coetzer, Rudi
Publicado: (2019)

Family socio‐economic status and childhood coeliac disease seem to be unrelated—A cross‐sectional screening study
por: Norström, Fredrik, et al.
Publicado: (2020)

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review
por: Sapkota, Alisha, et al.
Publicado: (2021)

Treatment of Adults With Treatment-Resistant Depression: Electroconvulsive Therapy Plus Antidepressant or Electroconvulsive Therapy Alone? Evidence From an Indirect Comparison Meta-Analysis
por: Song, Guo-Min, et al.
Publicado: (2015)

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)

The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
por: Pepe, Maria, et al.
Publicado: (2023)

Electroconvulsive Therapy and the Risk of Suicide in Hospitalized Patients With Major Depressive Disorder
por: Rönnqvist, Ida, et al.
Publicado: (2021)

Urothelial toxicity of esketamine in the treatment of depression
por: Findeis, Hannelore, et al.
Publicado: (2020)

Remission of treatment-resistant depression with tardive akathisia with electroconvulsive therapy
por: Emmanuel, Thanos
Publicado: (2019)

Neuroimaging study of electroconvulsive therapy for depression
por: Chen, Xiaolu, et al.
Publicado: (2023)

Esketamine for treatment‑resistant depression: A review of clinical evidence (Review)
por: Vasiliu, Octavian
Publicado: (2023)

Early real-life evaluation of the efficacy of esketamine in resistant depressive disorder
por: Faisant, S., et al.
Publicado: (2022)

Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients
por: Maier, Hannah Benedictine, et al.
Publicado: (2022)

Celiac disease and upper secondary school achievement in Sweden A retrospective cohort study
por: Johansson, Katarina, et al.
Publicado: (2022)

Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review
por: Salahudeen, Mohammed S, et al.
Publicado: (2020)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
por: Hernandez Huerta, D., et al.
Publicado: (2022)

Trajectories of Efficacy and Cognitive Function During Electroconvulsive Therapy Course in Young Adults with Treatment-Resistant Depression
por: Xu, Shu-xian, et al.
Publicado: (2023)

Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive Therapy
por: Pisanu, Claudia, et al.
Publicado: (2021)

Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression
por: Tominaga, Keiichiro, et al.
Publicado: (2011)

Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
por: Zincir, Serkan, et al.
Publicado: (2016)

Changes in White Matter Microstructure After Electroconvulsive Therapy for Treatment-Resistant Depression
por: Gryglewski, Gregor, et al.
Publicado: (2019)

Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model
por: Vallejo-Torres, L., et al.
Publicado: (2015)

Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2019)

Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression
por: Katz, Eva G., et al.
Publicado: (2020)

Esketamine: A Drug to Treat Resistant Depression That Brings More Questions Than Answers
por: Mischel, Nicholas A., et al.
Publicado: (2021)

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2021)

The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder
por: Daly, Ella J., et al.
Publicado: (2021)

Esketamine in patient with treatment resistant depression: Outcome of the temporary authorization for use programme in France
por: Wattinne, E. Gaudre, et al.
Publicado: (2021)

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression
por: Del Sant, Lorena Catarina, et al.
Publicado: (2022)

Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
por: Liu, Peng, et al.
Publicado: (2022)

Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression
por: Skala, Katrin, et al.
Publicado: (2023)

Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: Report of Two Clinical Cases
por: Mercado-Rodríguez, A., et al.
Publicado: (2023)

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder
por: Veraart, J.K.E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uk1tn7jtssti1ldvphkemfqn94